<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Burnell M</submitter><funding>The Eve Appeal</funding><funding>Medical Research Council</funding><funding>NIHR Biomedical Research Centre, University College London Hospitals</funding><funding>NHS Innovation Accelerator</funding><pagination>1970-1980</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9796935</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>129(12)</volume><pubmed_abstract>&lt;h4>Objective&lt;/h4>Ashkenazi-Jewish (AJ) population-based BRCA testing is acceptable, cost-effective and amplifies primary prevention for breast &amp; ovarian cancer. However, data describing lifestyle impact are lacking. We report long-term results of population-based BRCA testing on lifestyle behaviour and cancer risk perception.&lt;h4>Design&lt;/h4>Two-arm randomised controlled trials (ISRCTN73338115, GCaPPS): (a) population-screening (PS); (b) family history (FH)/clinical criteria testing.&lt;h4>Setting&lt;/h4>North London AJ-population.&lt;h4>Population/sample&lt;/h4>AJ women/men >18 years.&lt;h4>Exclusions&lt;/h4>prior BRCA testing or first-degree relatives of BRCA-carriers.&lt;h4>Methods&lt;/h4>Participants were recruited through self-referral. All participants received informed pre-test genetic counselling. The inte</pubmed_abstract><journal>BJOG : an international journal of obstetrics and gynaecology</journal><pubmed_title>Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term secondary lifestyle behavioural outcomes.</pubmed_title><pmcid>PMC9796935</pmcid><funding_grant_id>GTCV</funding_grant_id><funding_grant_id>PT</funding_grant_id><funding_grant_id>MC_UU_00004/01</funding_grant_id><pubmed_authors>Wardle J</pubmed_authors><pubmed_authors>Burnell M</pubmed_authors><pubmed_authors>Sanderson S</pubmed_authors><pubmed_authors>Legood R</pubmed_authors><pubmed_authors>Beller U</pubmed_authors><pubmed_authors>Sobocan M</pubmed_authors><pubmed_authors>Tomlinson I</pubmed_authors><pubmed_authors>Brady AF</pubmed_authors><pubmed_authors>Desai R</pubmed_authors><pubmed_authors>Loggenberg K</pubmed_authors><pubmed_authors>Jacobs I</pubmed_authors><pubmed_authors>Menon U</pubmed_authors><pubmed_authors>Gessler S</pubmed_authors><pubmed_authors>Gaba F</pubmed_authors><pubmed_authors>Dorkins H</pubmed_authors><pubmed_authors>Jacobs C</pubmed_authors><pubmed_authors>Side L</pubmed_authors><pubmed_authors>Wallis Y</pubmed_authors><pubmed_authors>Manchanda R</pubmed_authors></additional><is_claimable>false</is_claimable><name>Randomised trial of population-based BRCA testing in Ashkenazi Jews: long-term secondary lifestyle behavioural outcomes.</name><description>&lt;h4>Objective&lt;/h4>Ashkenazi-Jewish (AJ) population-based BRCA testing is acceptable, cost-effective and amplifies primary prevention for breast &amp; ovarian cancer. However, data describing lifestyle impact are lacking. We report long-term results of population-based BRCA testing on lifestyle behaviour and cancer risk perception.&lt;h4>Design&lt;/h4>Two-arm randomised controlled trials (ISRCTN73338115, GCaPPS): (a) population-screening (PS); (b) family history (FH)/clinical criteria testing.&lt;h4>Setting&lt;/h4>North London AJ-population.&lt;h4>Population/sample&lt;/h4>AJ women/men >18 years.&lt;h4>Exclusions&lt;/h4>prior BRCA testing or first-degree relatives of BRCA-carriers.&lt;h4>Methods&lt;/h4>Participants were recruited through self-referral. All participants received informed pre-test genetic counselling. The inte</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Nov</publication><modification>2025-04-04T10:59:00.284Z</modification><creation>2025-04-04T10:59:00.284Z</creation></dates><accession>S-EPMC9796935</accession><cross_references><pubmed>35781768</pubmed><doi>10.1111/1471-0528.17253</doi></cross_references></HashMap>